Skip to content

Callos Impact and Inject Bone Void Filler

by Skeletal Kinetics LLC

510(k) K051123

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

17 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK051123 Date3 Jun 2005ClearedStatusActive

Recalls

17 recalls · FDA

  • 11 recalls, same reason

    • Terminated Z-2593-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2611-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2594-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2607-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2623-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2592-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2610-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2622-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2620-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2606-2020 FDA Class II initiated 6 Apr 2020
    • Terminated Z-2621-2020 FDA Class II initiated 6 Apr 2020

    Bone void filler kits may not maintain its setting characteristics for the labeled shelf-life duration. Use may increase the required surgical and anesthesia time for the patient or possible longer-term health consequences could include incomplete bone formation or lack of bone formation, delayed union, or nonunion.

  • 5 recalls, same reason

    • Terminated Z-2180-2020 FDA Class II initiated 2 Apr 2020
    • Terminated Z-2182-2020 FDA Class II initiated 2 Apr 2020
    • Terminated Z-2184-2020 FDA Class II initiated 2 Apr 2020
    • Terminated Z-2181-2020 FDA Class II initiated 2 Apr 2020
    • Terminated Z-2183-2020 FDA Class II initiated 2 Apr 2020

    Incorrect shelf-life for bone void filler kits; the product may not maintain its setting characteristics for the labeled shelf-life duration.

    • Terminated Z-2209-2015 FDA Class II initiated 29 May 2015

    Reports of venous uptake, DVT, pulmonary embolism in patients who were implanted with Injection Plasty Bone Void Filler.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MQV
FDA applicant
Skeletal Kinetics, LLC
Device Class
Class II
Regulation
21 CFR Part 888.3045
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Skeletal Kinetics LLC

See all devices from Skeletal Kinetics LLC →